Ipsogen has announced that Helene Peyro-Saint-Paul has joined the company as chief medical officer.
Peyro-Saint-Paul will be in charge of all medical activities at Ipsogen and will contribute to the development and execution of the company's strategy.
Prior to joining Ipsogen, Peyro-Saint-Paul was European neuropsychiatry medical lead at Bristol-Myers Squibb.
Before that, she served as European medical affairs director, then strategic marketing director for metabolic diseases at Actelion.